SPAG9 Antikörper (N-Term)
Kurzübersicht für SPAG9 Antikörper (N-Term) (ABIN2293505)
Target
Alle SPAG9 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- N-Term
-
Kreuzreaktivität
- Human
-
Kreuzreaktivität (Details)
- Calculated cross reactivity: Hu
-
Produktmerkmale
- JLP, NT (JNK-associated Leucine-zipper Protein, Cancer/testis Antigen 89, CT89, HSS, Human Lung Cancer Oncogene 6 Protein, HLC6, HLC-6, c-Jun-amino-terminal Kinase-interacting Protein 4, JNK-interacting Protein 4, JIP4, JIP-4, KIAA0516, Mitogen-activated Protein Kinase 8-interacting Protein 4, MAPK8IP4, Proliferation-inducing Protein 6, PIG6, Protein Highly Expressed in Testis, PHET, Sperm Associated Antigen 9, SPAG9, Sperm-specific Protein, Sperm Surface Protein, Sunday Driver 1, SYD1)
-
Aufreinigung
- Purified by ammonium sulfate precipitation.
-
Immunogen
- Synthetic peptide selected from the N-terminal region of human SPAG9 (KLH).
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- Optimal working conditions should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- Supplied as a liquid in PBS, 0.09 % sodium azide.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- -20°C
-
-
- SPAG9 (Sperm Associated Antigen 9 (SPAG9))
-
Andere Bezeichnung
- JLP
-
NCBI Accession
- NP_003962
-
UniProt
- O60271
-
Pathways
- Regulation of Muscle Cell Differentiation
Target
-